Menu
Back to Journals » ImmunoTargets and Therapy » Volume 10
Review
Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,840 | Dovepress* | 4,800+ | 453 | 5,253 | |
| PubMed Central* | 2,040 | 273 | 2,313 | ||
| Totals | 6,840 | 726 | 7,566 | ||
| *Since 7 July 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 0 | 2 | 4 |
View citations on PubMed Central and Google Scholar